SCHEMBL2054718

SCHEMBL2054718

Cn1c(SCC2CC2)nnc1[C@H](CN1CCOCC1)NC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
TP53 P04637 1/20 0.34
POLB P06746 2/20 0.34
CD274 Q9NZQ7 1/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34
NPC1 O15118 1/20 0.34
ABL1 P00519 1/20 0.34
RIN1 Q13671 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CTSK P43235 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
JAK2 O60674 1/20 0.34
CNR2 P34972 2/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2096855 0.88 ALDH1A1 (0.45) TSHRKDM4EALDH1A1TP53POLB
SCHEMBL2054699 0.76 ALDH1A1 (0.38) TSHRKDM4EALDH1A1TP53POLB
SCHEMBL28548614 0.69 GPR88 (0.52) ALDH1A1TP53POLBMAPK1NPC1
SCHEMBL13852060 0.69 GPR88 (0.52) ALDH1A1TP53POLBMAPK1NPC1
SCHEMBL30843529 0.68 L3MBTL1 (0.48) TSHRKDM4EALDH1A1CD274MAPK1
SCHEMBL2255069 0.68 CTSK (0.49) ALDH1A1CD274NPC1MEN1KMT2A
SCHEMBL12260408 0.68 CTSK (0.49) ALDH1A1CD274NPC1MEN1KMT2A
SCHEMBL357027 0.68 CTSK (0.49) ALDH1A1CD274NPC1MEN1KMT2A
SCHEMBL30968576 0.67 CTSK (0.42) KDM4EALDH1A1CD274CTSK
SCHEMBL17828217 0.66 CTSK (0.43) TSHRALDH1A1CD274MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163956-B2 Inhibitors of GLYT1 transporters MERCK SHARP & DOHME CORP. (US) 2012-04-24 US disclosed
US-8163956-B2 Inhibitors of GLYT1 transporters MERCK SHARP & DOHME CORP. (US) 2012-04-24 US disclosed
US-20090286765-A1 Therapeutic Agents MERCK SHARP & DOHME (UK) LIMITED (GB) 2009-11-19 US disclosed
US-20090286765-A1 Therapeutic Agents MERCK SHARP & DOHME (UK) LIMITED (GB) 2009-11-19 US disclosed
WO-2006134341-A1 THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 2006-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286765-A1 Therapeutic Agents GRIA1, GRIN1, GLRA1 TSHR 774/4885KDM4E 4416/4885ALDH1A1 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.